Childhood-onset autosomal recessive myopathy with external ophthalmoplegia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:363677OMIM:605637G71.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Childhood-onset autosomal recessive myopathy with external ophthalmoplegia (ORPHA:363677) is an extremely rare inherited muscle disorder characterized by progressive skeletal muscle weakness beginning in childhood, accompanied by external ophthalmoplegia — a condition in which the muscles controlling eye movements become weakened or paralyzed, leading to limited eye mobility and often ptosis (drooping eyelids). The disease follows an autosomal recessive inheritance pattern, meaning a child must inherit two copies of the causative gene variant (one from each parent) to be affected. The condition primarily affects the skeletal muscular system, including the extraocular muscles and limb muscles. Patients typically present in childhood with progressive proximal muscle weakness affecting the limbs, difficulty with activities such as climbing stairs or rising from a seated position, and progressive limitation of eye movements. Facial weakness may also be present. Muscle biopsy findings are consistent with a myopathic process. The disease is classified under congenital myopathies (ICD-10: G71.2). There is currently no curative treatment for this condition. Management is supportive and multidisciplinary, focusing on physical therapy to maintain mobility and muscle function, ophthalmologic monitoring and intervention for ophthalmoplegia and ptosis, and respiratory surveillance if respiratory muscles become involved. Genetic counseling is recommended for affected families. Due to the extreme rarity of this condition, clinical data remain limited, and further research is needed to better characterize the natural history and identify potential therapeutic targets.

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Childhood-onset autosomal recessive myopathy with external ophthalmoplegia.

View clinical trials →

No actively recruiting trials found for Childhood-onset autosomal recessive myopathy with external ophthalmoplegia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Childhood-onset autosomal recessive myopathy with external ophthalmoplegia community →

No specialists are currently listed for Childhood-onset autosomal recessive myopathy with external ophthalmoplegia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Childhood-onset autosomal recessive myopathy with external ophthalmoplegia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Childhood-onset autosomal recessive myopathy with external ophthalmoplegiaForum →

No community posts yet. Be the first to share your experience with Childhood-onset autosomal recessive myopathy with external ophthalmoplegia.

Start the conversation →

Latest news about Childhood-onset autosomal recessive myopathy with external ophthalmoplegia

No recent news articles for Childhood-onset autosomal recessive myopathy with external ophthalmoplegia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Childhood-onset autosomal recessive myopathy with external ophthalmoplegia

What is Childhood-onset autosomal recessive myopathy with external ophthalmoplegia?

Childhood-onset autosomal recessive myopathy with external ophthalmoplegia (ORPHA:363677) is an extremely rare inherited muscle disorder characterized by progressive skeletal muscle weakness beginning in childhood, accompanied by external ophthalmoplegia — a condition in which the muscles controlling eye movements become weakened or paralyzed, leading to limited eye mobility and often ptosis (drooping eyelids). The disease follows an autosomal recessive inheritance pattern, meaning a child must inherit two copies of the causative gene variant (one from each parent) to be affected. The conditi

How is Childhood-onset autosomal recessive myopathy with external ophthalmoplegia inherited?

Childhood-onset autosomal recessive myopathy with external ophthalmoplegia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Childhood-onset autosomal recessive myopathy with external ophthalmoplegia typically begin?

Typical onset of Childhood-onset autosomal recessive myopathy with external ophthalmoplegia is childhood. Age of onset can vary across affected individuals.